Citations (163)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Maryam Owrangi, Mohammad Javad Gholamzadeh, Maryam Vasaghi Gharamaleki, Seyedeh Zahra Mousavi, Ali-Mohammad Kamali, Mehdi Dehghani, Prasun Chakrabarti & Mohammad Nami. (2022) Comparative Analysis of the Chemotherapy-Related Cognitive Impairments in Patients with Breast Cancer: A Community-Based Research. Cancer Investigation 40:9, pages 811-821.
Read now
Read now
Maverick Clissold & Simon F. Crowe. (2019) Comparing the effect of the subcategories of atypical antipsychotic medications on cognition in schizophrenia using a meta-analytic approach. Journal of Clinical and Experimental Neuropsychology 41:1, pages 26-42.
Read now
Read now
Jennifer E. Swanberg, Helen M. Nichols, Jungyai Ko, J. Kathleen Tracy & Robin C. Vanderpool. (2017) Managing cancer and employment: Decisions and strategies used by breast cancer survivors employed in low-wage jobs. Journal of Psychosocial Oncology 35:2, pages 180-201.
Read now
Read now
Daniel Sj Costa, Rebecca Mercieca‐bebber, Claudia Rutherford, Liam Gabb & Madeleine T King. (2016) The Impact of Cancer on Psychological and Social Outcomes. Australian Psychologist 51:2, pages 89-99.
Read now
Read now
Elizabeth K. Stranks & Simon F. Crowe. (2014) The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: A systematic review and meta-analysis. Journal of Clinical and Experimental Neuropsychology 36:7, pages 691-700.
Read now
Read now
Aude Caplette-Gingras, Josée Savard, Marie-Hélène Savard & Hans Ivers. (2013) Is Insomnia Associated With Cognitive Impairments in Breast Cancer Patients?. Behavioral Sleep Medicine 11:4, pages 239-257.
Read now
Read now
Johanna Skoogh, Gunnar Steineck, Ulrika Stierner, Eva Cavallin-Ståhl, Ulrica Wilderäng, Anders Wallin, Margaret Gatz & Boo Johansson. (2012) Testicular-cancer survivors experience compromised language following chemotherapy: Findings in a Swedish population-based study 3–26 years after treatment. Acta Oncologica 51:2, pages 185-197.
Read now
Read now
Philip
G. Gasquoine. (2011) Cognitive impairment in common, noncentral nervous system medical conditions of adults and the elderly. Journal of Clinical and Experimental Neuropsychology 33:4, pages 486-496.
Read now
Read now
Marianne Ewertz & Anders Bonde Jensen. (2011) Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncologica 50:2, pages 187-193.
Read now
Read now
Yaacov R Lawrence, Wenyin Shi & Adam P Dicker. (2010) From survival to survivorship: late side effects become an issue in high-grade glioma. Expert Review of Neurotherapeutics 10:10, pages 1493-1495.
Read now
Read now
Bernadine Cimprich, Patricia Reuter-Lorenz, James Nelson, Patricia
M. Clark, Barbara Therrien, Daniel Normolle, Marc
G. Berman, Daniel
F. Hayes, Douglas
C. Noll, Scott Peltier & Robert
C. Welsh. (2010) Prechemotherapy alterations in brain function in women with breast cancer. Journal of Clinical and Experimental Neuropsychology 32:3, pages 324-331.
Read now
Read now
Katharine Jean Vearncombe & Nancy A. Pachana. (2009) Impact of health, treatment and psychological factors on cognitive functioning after chemotherapy for early breast cancer. Australian Psychologist 44:4, pages 235-247.
Read now
Read now
StephanieA. Reid-Arndt, Albert Yee, MichaelC. Perry & Catherine Hsieh. (2009) Cognitive and Psychological Factors Associated with Early Posttreatment Functional Outcomes in Breast Cancer Survivors. Journal of Psychosocial Oncology 27:4, pages 415-434.
Read now
Read now
Diane Von Ah, Kyle W. Harvison, Patrick O. Monahan, Lyndsi R. Moser, Qianqian Zhao, Janet S. Carpenter, George W. Sledge Jr, Victoria L. Champion & Frederick W. Unverzagt. (2009) Cognitive Function in Breast Cancer Survivors Compared to Healthy Age- and Education-Matched Women. The Clinical Neuropsychologist 23:4, pages 661-674.
Read now
Read now
L. A. Ouimet, A. Stewart, B. Collins, D. Schindler & C. Bielajew. (2009) Measuring neuropsychological change following breast cancer treatment: An analysis of statistical models. Journal of Clinical and Experimental Neuropsychology 31:1, pages 73-89.
Read now
Read now
Christina M. Schilder, Petronella C. Eggens, Caroline Seynaeve, Sabine C. Linn, Willem Boogerd, Chad M. Gundy, Louk V. Beex, Frits S. Van Dam & Sanne B. Schagen. (2009) Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: Cross-sectional findings from the neuropsychological TEAM-side study. Acta Oncologica 48:1, pages 76-85.
Read now
Read now
T. Taskila & M. L. Lindbohm. (2007) Factors affecting cancer survivors' employment and work ability. Acta Oncologica 46:4, pages 446-451.
Read now
Read now
GeorgeJ. Demakis. (2006) Meta-Analysis in Neuropsychology: An Introduction. The Clinical Neuropsychologist 20:1, pages 5-9.
Read now
Read now
Articles from other publishers (145)
Pedro F. S. Rodrigues, Ana Bártolo & Pedro B. Albuquerque. (2023) Memory Impairments and Wellbeing in Breast Cancer Patients: A Systematic Review. Journal of Clinical Medicine 12:22, pages 6968.
Crossref
Crossref
Taichi Goto, Diane Von Ah, Xiaobai Li, Lichen Xiang, Catherine Kwiat, Christopher Nguyen, Chao-Pin Hsiao & Leorey N. Saligan. (2023) Brain-Derived Neurotrophic Factor rs6265 polymorphism is associated with severe cancer-related fatigue and neuropathic pain in female cancer survivors. Journal of Cancer Survivorship.
Crossref
Crossref
Diane Von Ah, Adele Crouch, Elizabeth Arthur, Yesol Yang & Timiya Nolan. (2023) Association Between Cardiovascular Disease and Cognitive Dysfunction in Breast Cancer Survivors. Cancer Nursing 46:2, pages E122-E128.
Crossref
Crossref
Lisa M. Jaremka, Megan A. Nadzan & Naoyuki Sunami. 2023.
277
338
.
Benjamin Ongnok, Chayodom Maneechote, Titikorn Chunchai, Patcharapong Pantiya, Busarin Arunsak, Wichwara Nawara, Nipon Chattipakorn & Siriporn C. Chattipakorn. (2022) Modulation of mitochondrial dynamics rescues cognitive function in rats with ‘doxorubicin‐induced chemobrain’ via mitigation of mitochondrial dysfunction and neuroinflammation. The FEBS Journal 289:20, pages 6435-6455.
Crossref
Crossref
Alexandra M. Gaynor, Tim A. Ahles, Elizabeth Ryan, Elizabeth Schofield, Yuelin Li, Sunita K. Patel, Katrazyna McNeal, Tiffany Traina & James C. Root. (2021) Initial encoding deficits with intact memory retention in older long-term breast cancer survivors. Journal of Cancer Survivorship 16:5, pages 940-947.
Crossref
Crossref
Alexandra C. Apple, Cutter A. Lindbergh, Susan M. Landau, Amy DeLuca, Jamie L. Eberling, William J. Jagust, Joel H. Kramer, Hope S. Rugo & Lara H. Heflin. (2022) Longitudinal Trajectories of Memory Performance in Patients with Early-Stage Breast Cancer. Journal of Oncology 2022, pages 1-9.
Crossref
Crossref
Adele Crouch, Victoria Champion & Diane Von Ah. (2022) Cognitive Dysfunction in Older Breast Cancer Survivors. Cancer Nursing 45:1, pages E162-E178.
Crossref
Crossref
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, Sri Pragnya Cheruku, V. Ravichandiran & Nitesh Kumar. 2022. Strategies to Mitigate the Toxicity of Cancer Therapeutics. Strategies to Mitigate the Toxicity of Cancer Therapeutics
29
76
.
Lien D. Nguyen, Tom T. Fischer & Barbara E. Ehrlich. (2021) Pharmacological rescue of cognitive function in a mouse model of chemobrain. Molecular Neurodegeneration 16:1.
Crossref
Crossref
Soo Young Hwang, Kwanghyun Kim, Byeonggwan Ha, Dongkyu Lee, Seonung Kim, Seongjun Ryu, Jisu Yang & Sun Jae Jung. (2021) Neurocognitive Effects of Chemotherapy for Colorectal Cancer: A Systematic Review and a Meta-Analysis of 11 Studies. Cancer Research and Treatment 53:4, pages 1134-1147.
Crossref
Crossref
Michael J. Boivin, Alla Sikorskii, Pamela Haan, Stephanie S. Smith, Laura L. Symonds, Ravindra Khattree, Bruno Giordani, Adrian J. Blow & Janet R. Osuch. (2021) Health-Related Quality of Life: Longitudinal Analysis From the Time of Breast Biopsy Into the Post-treatment Period. Frontiers in Global Women's Health 2.
Crossref
Crossref
Nicole Chmielewski-Stivers, Benoit Petit, Jonathan Ollivier, Virginie Monceau, Pelagia Tsoutsou, Ana Quintela Pousa, Xiaomeng Lin, Charles Limoli & Marie-Catherine Vozenin. (2021) Sex-Specific Differences in Toxicity Following Systemic Paclitaxel Treatment and Localized Cardiac Radiotherapy. Cancers 13:16, pages 3973.
Crossref
Crossref
Helena Carreira, Rachael Williams, Harley Dempsey, Susannah Stanway, Liam Smeeth & Krishnan Bhaskaran. (2020) Quality of life and mental health in breast cancer survivors compared with non-cancer controls: a study of patient-reported outcomes in the United Kingdom. Journal of Cancer Survivorship 15:4, pages 564-575.
Crossref
Crossref
Diane Von Ah & Adele Crouch. (2021) Relationship of perceived everyday cognitive function and work engagement in breast cancer survivors. Supportive Care in Cancer 29:8, pages 4303-4309.
Crossref
Crossref
Hye Yoon Park, Hyeongrae Lee, Joohyuk Sohn, Suk Kyoon An, Kee Namkoong & Eun Lee. (2021) Increased resting-state cerebellar-cortical connectivity in breast cancer survivors with cognitive complaints after chemotherapy. Scientific Reports 11:1.
Crossref
Crossref
Aicha B. C. Dijkshoorn, Haike E. van Stralen, Maurits Sloots, Sanne B. Schagen, Johanna M. A. Visser‐Meily & Vera P. M. Schepers. (2021) Prevalence of cognitive impairment and change in patients with breast cancer: A systematic review of longitudinal studies. Psycho-Oncology 30:5, pages 635-648.
Crossref
Crossref
Jaidyn Muhandiramge, Suzanne Orchard, Andrew Haydon & John Zalcberg. (2021) The acceleration of ageing in older patients with cancer. Journal of Geriatric Oncology 12:3, pages 343-351.
Crossref
Crossref
Brenna C. McDonald. (2021) Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction. Neurotherapeutics 18:2, pages 792-810.
Crossref
Crossref
Ruairí Floyd, Adam H. Dyer & Seán P. Kennelly. (2021) Non-pharmacological interventions for cognitive impairment in women with breast cancer post-chemotherapy: A systematic review. Journal of Geriatric Oncology 12:2, pages 173-181.
Crossref
Crossref
Jennifer Brunet, Meagan Barrett-Bernstein, Kendra Zadravec, Monica Taljaard, Nathalie LeVasseur, Amirrtha Srikanthan, Kelcey A. Bland, Barbara Collins, Julia W. Y. Kam, Todd C. Handy, Sherri Hayden, Christine Simmons, Andra M. Smith, Naznin Virji-Babul & Kristin L. Campbell. (2020) Study protocol of the Aerobic exercise and CogniTIVe functioning in women with breAsT cancEr (ACTIVATE) trial: a two-arm, two-centre randomized controlled trial. BMC Cancer 20:1.
Crossref
Crossref
Taishan Tong, Heng Lu, Jian Zong, Qing Lv & Xing Chu. (2020) Chemotherapy-related cognitive impairment in patients with breast cancer based on MRS and DTI analysis. Breast Cancer 27:5, pages 893-902.
Crossref
Crossref
Sarah Eide & Zhong-Ping Feng. (2020) Doxorubicin chemotherapy-induced “chemo-brain”: Meta-analysis. European Journal of Pharmacology 881, pages 173078.
Crossref
Crossref
Esther Baumann, Katharina Kuba, Heide Götze, Anja Mehnert‐Theuerkauf & Peter Esser. (2020) Initial validation of the German version of the Attentional Function Index in a sample of haematological cancer survivors. European Journal of Cancer Care 29:4.
Crossref
Crossref
Lien D Nguyen & Barbara E Ehrlich. (2020) Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases. EMBO Molecular Medicine 12:6.
Crossref
Crossref
Hee‐Ju Kim, Sun‐Ok Jung, Hyang Kim & Ivo Abraham. (2020) Systematic review of longitudinal studies on chemotherapy‐associated subjective cognitive impairment in cancer patients. Psycho-Oncology 29:4, pages 617-631.
Crossref
Crossref
Diane Von Ah & Adele Crouch. (2020) Cognitive Rehabilitation for Cognitive Dysfunction after Cancer and Cancer Treatment: Implications for Nursing Practice. Seminars in Oncology Nursing 36:1, pages 150977.
Crossref
Crossref
Joy Perrier, Armelle Viard, Christelle Levy, Nastassja Morel, Djelila Allouache, Sabine Noal, Florence Joly, Francis Eustache & Bénédicte Giffard. (2018) Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: impact of education level. Brain Imaging and Behavior 14:1, pages 226-241.
Crossref
Crossref
Zhou Xu, Feng Luo, Yu Wang, Bao-shan Zou, Yuan Man, Jia-shuo Liu, Hao Li, Bilal Arshad, Hong Li, Shu Li, Yu-xian Wei, Hong-yuan Li, Kai-nan Wu & Ling-quan Kong. (2019) Cognitive impairments in breast cancer survivors treated with chemotherapy: a study based on event-related potentials. Cancer Chemotherapy and Pharmacology 85:1, pages 61-67.
Crossref
Crossref
Todd S Horowitz, Melissa Treviño, Ingrid M Gooch & Korrina A Duffy. (2019) Understanding the Profile of Cancer-Related Cognitive Impairments: A Critique of Meta-Analyses. JNCI: Journal of the National Cancer Institute 111:10, pages 1009-1015.
Crossref
Crossref
Jin-Hee Park, Yong Sik Jung, Young-Mi Jung & Sun Hyoung Bae. (2018) The role of depression in the relationship between cognitive decline and quality of life among breast cancer patients. Supportive Care in Cancer 27:7, pages 2707-2714.
Crossref
Crossref
Artemis Papanastasiou, Theodora Seliniotaki, Emmanouil Rizos, Katerina Kampoli, Anastasios Ntavatzikos, Nikolaos Arkadopoulos, Christina Tsionou, Demetrios Spandidos & Anna Koumarianou. (2019) Role of stress, age and adjuvant therapy in the cognitive function of patients with breast cancer (Review). Oncology Letters.
Crossref
Crossref
Manuela Vasconcelos Castro Sales, Claudia K. Suemoto, Daniel Apolinario, ValeriaT. Serrao, Celi S. Andrade, David M. Conceição, Edson AmaroJr.Jr., Brian Alvarez Ribeiro de Melo & Rachel P. Riechelmann. (2019) Effects of Adjuvant Chemotherapy on Cognitive Function of Patients With Early-stage Colorectal Cancer. Clinical Colorectal Cancer 18:1, pages 19-27.
Crossref
Crossref
Simon F Crowe & Elizabeth K Stranks. (2018) The Residual Medium and Long-term Cognitive Effects of Benzodiazepine Use: An Updated Meta-analysis. Archives of Clinical Neuropsychology 33:7, pages 901-911.
Crossref
Crossref
Rimke Bijker, Saskia F. A. Duijts, Sherzel N. Smith, Renée de Wildt-Liesveld, Johannes R. Anema & Barbara J. Regeer. (2017) Functional Impairments and Work-Related Outcomes in Breast Cancer Survivors: A Systematic Review. Journal of Occupational Rehabilitation 28:3, pages 429-451.
Crossref
Crossref
Lindsay L. Peterson & Jennifer A. Ligibel. (2018) Physical Activity and Breast Cancer: an Opportunity to Improve Outcomes. Current Oncology Reports 20:7.
Crossref
Crossref
Jane H. Cerhan, Alissa M. Butts, Michael W. Parsons & Paul D. Brown. 2018. Adult CNS Radiation Oncology. Adult CNS Radiation Oncology
591
603
.
K.L. Campbell, J.W.Y. Kam, S.E. Neil‐Sztramko, T. Liu Ambrose, T.C. Handy, H.J. Lim, S. Hayden, L. Hsu, A.A. Kirkham, C.C. Gotay, D.C. McKenzie & L.A. Boyd. (2017)
Effect of aerobic exercise on cancer‐associated cognitive impairment: A proof‐of‐concept
RCT
. Psycho-Oncology 27:1, pages 53-60.
Crossref
Crossref
Lori J. Bernstein, Graham A. McCreath, Zahra Komeylian & Jill B. Rich. (2017) Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis. Neuroscience & Biobehavioral Reviews 83, pages 417-428.
Crossref
Crossref
Marie-Rose Dwek, Lorna Rixon, Catherine Hurt, Alice Simon & Stanton Newman. (2017) Is there a relationship between objectively measured cognitive changes in patients with solid tumours undergoing chemotherapy treatment and their health-related quality of life outcomes? A systematic review. Psycho-Oncology 26:10, pages 1422-1432.
Crossref
Crossref
Paul Ritvo, Maya Obadia, Daniel Santa Mina, Shabbir Alibhai, Catherine Sabiston, Paul Oh, Kristin Campbell, David McCready, Leslie Auger & Jennifer Michelle Jones. (2017) Smartphone-Enabled Health Coaching Intervention (iMOVE) to Promote Long-Term Maintenance of Physical Activity in Breast Cancer Survivors: Protocol for a Feasibility Pilot Randomized Controlled Trial. JMIR Research Protocols 6:8, pages e165.
Crossref
Crossref
P Huehnchen, W Boehmerle, A Springer, D Freyer & M Endres. (2017) A novel preventive therapy for paclitaxel-induced cognitive deficits: preclinical evidence from C57BL/6 mice. Translational Psychiatry 7:8, pages e1185-e1185.
Crossref
Crossref
Icro Meattini, Isacco Desideri, Giulio Francolini, Agnese Vannini, Marco Perna, Pietro Garlatti, Roberta Grassi & Lorenzo Livi. (2017) Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature. Medical Oncology 34:5.
Crossref
Crossref
Magdalena Bury. (2017) Review paper. Chemobrain in patients suffering from cancer based on the example of multiple myeloma. Current Problems of Psychiatry 18:1, pages 62-69.
Crossref
Crossref
Lisa A. S. Walker, Jason A. Berard, Marjorie Bowman, Harold L. Atkins, Hyunwoo Lee, Douglas Arnold & Mark S. Freedman. (2016) Longitudinal change in Paced Auditory Serial Addition Test (PASAT) performance following immunoablative therapy and haematopoietic stem cell transplant in multiple sclerosis. Multiple Sclerosis and Demyelinating Disorders 1:1.
Crossref
Crossref
MF Damholdt, M Mehlsen, MS O'Toole, RK Andreasen, AD Pedersen & R Zachariae. (2016) Web‐based cognitive training for breast cancer survivors with cognitive complaints—a randomized controlled trial. Psycho-Oncology 25:11, pages 1293-1300.
Crossref
Crossref
Filipa Fontes, Susana Pereira, José Manuel Castro-Lopes & Nuno Lunet. (2016) A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis. The Breast 29, pages 31-38.
Crossref
Crossref
Pok-Ja Oh & Ji Kim. (2016) The Effects of Nonpharmacologic Interventions on Cognitive Function in Patients With Cancer: A Meta-Analysis. Oncology Nursing Forum 43:5, pages E205-E217.
Crossref
Crossref
Diane Ah, Susan Storey, Eileen Tallman, Adele Nielsen, Shelley Johns & Susan Pressler. (2016) Cancer, Cognitive Impairment, and Work-Related Outcomes: An Integrative Review. Oncology Nursing Forum 43:5, pages 602-616.
Crossref
Crossref
Venkadesan Rajendran & Deepa Jeevanantham. (2016) Assessment of physical function in geriatric oncology based on International Classification of Functioning, Disability and Health (ICF) framework. Current Geriatrics Reports 5:3, pages 200-212.
Crossref
Crossref
Krystle E. Zuniga, Michael J. Mackenzie, Sarah A. Roberts, Lauren B. Raine, Charles H. Hillman, Arthur F. Kramer & Edward McAuley. (2015) Relationship between fruit and vegetable intake and interference control in breast cancer survivors. European Journal of Nutrition 55:4, pages 1555-1562.
Crossref
Crossref
Karin Olson, Joanne Hewit, Linda G. Slater, Thane Chambers, Deborah Hicks, Anna Farmer, Kathryn Grattan, Shawn Steggles & Bryan Kolb. (2016) Assessing cognitive function in adults during or following chemotherapy: a scoping review. Supportive Care in Cancer.
Crossref
Crossref
Elizabeth K. Stranks & Simon F. Crowe. (2016) The Cognitive Effects of Obstructive Sleep Apnea: An Updated Meta-analysis. Archives of Clinical Neuropsychology, pages acv087.
Crossref
Crossref
Helena Harder & Valerie Jenkins. 2016. Breast Cancer Survivorship. Breast Cancer Survivorship
235
247
.
Andy S. K. Cheng, Yingchun Zeng & Michael Feuerstein. (2015) Validation of the Chinese Version of the Cognitive Symptom Checklist-Work-21 in Breast Cancer Survivors. Journal of Occupational Rehabilitation 25:4, pages 685-695.
Crossref
Crossref
Susana Pereira, Filipa Fontes, Teresa Sonin, Teresa Dias, Maria Fragoso, José Manuel Castro-Lopes & Nuno Lunet. (2015) Neurological complications of breast cancer: A prospective cohort study. The Breast 24:5, pages 582-587.
Crossref
Crossref
Giovanni G. Arcuri, Lisa Palladini, Gabrielle Dumas, Josée Lemoignan & Bruno Gagnon. (2015) Exploring the measurement properties of the Montreal Cognitive Assessment in a population of people with cancer. Supportive Care in Cancer 23:9, pages 2779-2787.
Crossref
Crossref
Jin-Hee Park, Sun Hyoung Bae, Yong Sik Jung & Young-Mi Jung. (2015) The psychometric properties of the Korean version of the functional assessment of cancer therapy-cognitive (FACT-Cog) in Korean patients with breast cancer. Supportive Care in Cancer 23:9, pages 2695-2703.
Crossref
Crossref
Hiromichi Matsuoka, Kazuhiro Yoshiuchi, Atsuko Koyama, Masatomo Otsuka & Kazuhiko Nakagawa. (2014) Chemotherapeutic drugs that penetrate the blood–brain barrier affect the development of hyperactive delirium in cancer patients. Palliative and Supportive Care 13:4, pages 859-864.
Crossref
Crossref
James C. Root, Elizabeth Ryan, Gregory Barnett, Charissa Andreotti, Kemi Bolutayo & Tim Ahles. (2015) Learning and memory performance in a cohort of clinically referred breast cancer survivors: the role of attention versus forgetting in patient-reported memory complaints. Psycho-Oncology 24:5, pages 548-555.
Crossref
Crossref
Diane Von Ah & Eileen F. Tallman. (2015) Perceived Cognitive Function in Breast Cancer Survivors: Evaluating Relationships With Objective Cognitive Performance and Other Symptoms Using the Functional Assessment of Cancer Therapy—Cognitive Function Instrument. Journal of Pain and Symptom Management 49:4, pages 697-706.
Crossref
Crossref
Miyuki Ono, James M. Ogilvie, Jennifer S. Wilson, Heather J. Green, Suzanne K. Chambers, Tamara Ownsworth & David H. K. Shum. (2015) A Meta-Analysis of Cognitive Impairment and Decline Associated with Adjuvant Chemotherapy in Women with Breast Cancer. Frontiers in Oncology 5.
Crossref
Crossref
Diane Von Ah. (2015) Cognitive Changes Associated With Cancer and Cancer Treatment: State of the Science. Clinical Journal of Oncology Nursing 19:1, pages 47-56.
Crossref
Crossref
Jin-Hee ParkSun Hyoung BaeYong-Sik JungYoung-Mi Jung. (2015) Prevalence and Characteristics of Chemotherapy-related Cognitive Impairment in Patients with Breast Cancer. Journal of Korean Academy of Nursing 45:1, pages 118.
Crossref
Crossref
Diane Von Ah, Catherine E. Jansen & Deborah H. Allen. (2014) Evidence-Based Interventions for Cancer- and Treatment-Related Cognitive Impairment. Clinical Journal of Oncology Nursing 18:s6, pages 17-25.
Crossref
Crossref
Chris Lepage, Andra M Smith, Jeremy Moreau, Emily Barlow-Krelina, Nancy Wallis, Barbara Collins, Joyce MacKenzie & Carole Scherling. (2014) A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients. SpringerPlus 3:1.
Crossref
Crossref
Lisa M. Jaremka, Juan Peng, Robert Bornstein, Catherine M. Alfano, Rebecca R. Andridge, Stephen P. Povoski, Adele M. Lipari, Doreen M. Agnese, William B. Farrar, Lisa D. Yee, William E. CarsonIIIIII & Janice K. Kiecolt-Glaser. (2014) Cognitive problems among breast cancer survivors: loneliness enhances risk. Psycho-Oncology 23:12, pages 1356-1364.
Crossref
Crossref
Jeanne S. MandelblattPaul B. JacobsenTim Ahles. (2014) Cognitive Effects of Cancer Systemic Therapy: Implications for the Care of Older Patients and Survivors. Journal of Clinical Oncology 32:24, pages 2617-2626.
Crossref
Crossref
Stefan Feiten, Jan Dünnebacke, Jochen Heymanns, Hubert Köppler, Jörg Thomalla, Christoph van Roye, Diana Wey & Rudolf Weide. (2014) Breast Cancer Morbidity. Deutsches Ärzteblatt international.
Crossref
Crossref
Pascal Jean-Pierre, Douglas Johnson-Greene & Thomas G. Burish. (2014) Neuropsychological care and rehabilitation of cancer patients with chemobrain: strategies for evaluation and intervention development. Supportive Care in Cancer 22:8, pages 2251-2260.
Crossref
Crossref
Juan Antonio Cruzado, Sonia López-Santiago, Virginia Martínez-Marín, Gema José-Moreno, Ana Belén Custodio & Jaime Feliu. (2014) Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients. Supportive Care in Cancer 22:7, pages 1815-1823.
Crossref
Crossref
Jeanne S. MandelblattRobert A. SternGheorghe LutaMeghan McGuckinJonathan D. ClappArti HurriaPaul B. JacobsenLeigh Anne FaulClaudine IsaacsNeelima DenduluriBrandon GavettTiffany A. TrainaPatricia JohnsonRebecca A. SillimanR. Scott TurnerDarlene HowardJohn W. Van MeterAndrew SaykinTim Ahles. (2014) Cognitive Impairment in Older Patients With Breast Cancer Before Systemic Therapy: Is There an Interaction Between Cancer and Comorbidity?. Journal of Clinical Oncology 32:18, pages 1909-1918.
Crossref
Crossref
Stewart M. Bond, Deborah K. Hawkins & Barbara A. Murphy. (2014) Caregiver-Reported Neuropsychiatric Symptoms in Patients Undergoing Treatment for Head and Neck Cancer. Cancer Nursing 37:3, pages 227-235.
Crossref
Crossref
Jochen Kaiser, Christoph Bledowski & Jörg Dietrich. (2014) Neural correlates of chemotherapy-related cognitive impairment. Cortex 54, pages 33-50.
Crossref
Crossref
Kim Edelstein & Lori J. Bernstein. (2014) Cognitive Dysfunction after Chemotherapy For Breast Cancer. Journal of the International Neuropsychological Society 20:4, pages 351-356.
Crossref
Crossref
M. Tish Knobf, A. Siobhan Thompson, Kristopher Fennie & Diane Erdos. (2014) The Effect of a Community-Based Exercise Intervention on Symptoms and Quality of Life. Cancer Nursing 37:2, pages E43-E50.
Crossref
Crossref
Jamie Arndt, Enny Das, Sanne B. Schagen, Stephanie A. Reid-Arndt, Linda D. Cameron & Tim A. Ahles. (2014) Broadening the cancer and cognition landscape: the role of self-regulatory challenges. Psycho-Oncology 23:1, pages 1-8.
Crossref
Crossref
Adeline Rollin-Sillaire, Xavier Delbeuck, Marianne Pollet, Marie-Anne Mackowiak, Pierre Lenfant, Marie-Pierre Noel, Thierry Facon, Xavier Leleu, Florence Pasquier & Emilie Le Rhun. (2013) Memory loss during lenalidomide treatment: a report on two cases. BMC Pharmacology and Toxicology 14:1.
Crossref
Crossref
Jeanne S. Mandelblatt, Arti Hurria, Brenna C. McDonald, Andrew J. Saykin, Robert A. Stern, John W. VanMeter, Meghan McGuckin, Tiffani Traina, Neelima Denduluri, Scott Turner, Darlene Howard, Paul B. Jacobsen & Tim Ahles. (2013) Cognitive Effects of Cancer and Its Treatments at the Intersection of Aging: What Do We Know; What Do We Need to Know?. Seminars in Oncology 40:6, pages 709-725.
Crossref
Crossref
Andrew J. Saykin, Michiel B. de Ruiter, Brenna C. McDonald, Sabine Deprez & Daniel H. S. Silverman. (2013) Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: Current status and recommendations for future research. Brain Imaging and Behavior 7:4, pages 363-373.
Crossref
Crossref
Wendy L. Nelson & Jerry Suls. (2013) New Approaches to Understand Cognitive Changes Associated With Chemotherapy for Non-Central Nervous System Tumors. Journal of Pain and Symptom Management 46:5, pages 707-721.
Crossref
Crossref
Lise Paquet, Barbara Collins, Xinni Song, Anne Chinneck, Marc Bedard & Shailendra Verma. (2013) A pilot study of prospective memory functioning in early breast cancer survivors. The Breast 22:4, pages 455-461.
Crossref
Crossref
Erin O’Farrell, Joyce MacKenzie & Barbara Collins. (2013) Clearing the Air: A Review of Our Current Understanding of “Chemo Fog”. Current Oncology Reports 15:3, pages 260-269.
Crossref
Crossref
B. Jonius, Y. Libert, I. Bragard, C. Reynaert, D. Razavi & A. -M. Étienne. (2013) Les fonctions cognitives au commencement d’une nouvelle ligne de traitement chez des patients âgés atteints d’un cancer hématologiqueCognitive functions at the beginning of a new course of treatment in elderly patients with hematologic cancer. Psycho-Oncologie 7:2, pages 118-129.
Crossref
Crossref
Diane Von Ah, Barbara Habermann, Janet S. Carpenter & Brandy L. Schneider. (2013) Impact of perceived cognitive impairment in breast cancer survivors. European Journal of Oncology Nursing 17:2, pages 236-241.
Crossref
Crossref
Christopher M. Nguyen, Torricia H. Yamada, Leigh J. Beglinger, Joseph E. Cavanaugh, Natalie L. Denburg & Susan K. Schultz. (2012) Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions. Psycho-Oncology 22:4, pages 862-868.
Crossref
Crossref
Brenna C. McDonald, Susan K. Conroy, Dori J. Smith, John D. West & Andrew J. Saykin. (2013) Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study. Brain, Behavior, and Immunity 30, pages S117-S125.
Crossref
Crossref
Susan K. Conroy, Brenna C. McDonald, Dori J. Smith, Lyndsi R. Moser, John D. West, Lisa M. Kamendulis, James E. Klaunig, Victoria L. Champion, Frederick W. Unverzagt & Andrew J. Saykin. (2012) Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage. Breast Cancer Research and Treatment 137:2, pages 493-502.
Crossref
Crossref
Bruno Vellas & Phillipe RobertC. Gaudin. 2013. Traité sur la maladie d’Alzheimer. Traité sur la maladie d’Alzheimer
297
305
.
D. Howell, T. F. Hack, T. K. Oliver, T. Chulak, S. Mayo, M. Aubin, M. Chasen, C. C. Earle, A. J. Friedman, E. Green, G. W. Jones, J. M. Jones, M. Parkinson, N. Payeur, C. M. Sabiston & S. Sinclair. (2012) Models of care for post-treatment follow-up of adult cancer survivors: a systematic review and quality appraisal of the evidence. Journal of Cancer Survivorship 6:4, pages 359-371.
Crossref
Crossref
Heather S.L. JimKristin M. PhillipsSari ChaitLeigh Anne FaulMihaela A. PopaYun-Hsiang LeeMallory G. HussinPaul B. JacobsenBrent J. Small. (2012) Meta-Analysis of Cognitive Functioning in Breast Cancer Survivors Previously Treated With Standard-Dose Chemotherapy. Journal of Clinical Oncology 30:29, pages 3578-3587.
Crossref
Crossref
Victoria A. Shaffer, Edgar C. Merkle, Angela Fagerlin, Jennifer J. Griggs, Kenneth M. Langa & Theodore J. Iwashyna. (2012) Chemotherapy Was Not Associated With Cognitive Decline in Older Adults With Breast and Colorectal Cancer. Medical Care 50:10, pages 849-855.
Crossref
Crossref
Diane Von Ah, Janet S. Carpenter, Andrew Saykin, Patrick Monahan, Jingwei Wu, Menggang Yu, George Rebok, Karlene Ball, Bryan Schneider, Michael Weaver, Eileen Tallman & Fred Unverzagt. (2012) Advanced cognitive training for breast cancer survivors: a randomized controlled trial. Breast Cancer Research and Treatment 135:3, pages 799-809.
Crossref
Crossref
Joseph M. Andreano, James Waisman, Lisa Donley & Larry Cahill. (2011) Effects of breast cancer treatment on the hormonal and cognitive consequences of acute stress. Psycho-Oncology 21:10, pages 1091-1098.
Crossref
Crossref
P. Frémont, L. Balardy, D. Faramarzi-Roques, L. Goldblatt, G. Kouri, I. Latorzeff, L. Mourey, G. Pasticier, F. Vavdin & P. Rischmann. (2012) Troubles de l’humeur et cognitifs et suppression androgénique. Progrès en Urologie 22, pages S64-S71.
Crossref
Crossref
Brenna C. McDonaldSusan K. ConroyTim A. AhlesJohn D. WestAndrew J. Saykin. (2012) Alterations in Brain Activation During Working Memory Processing Associated With Breast Cancer and Treatment: A Prospective Functional Magnetic Resonance Imaging Study. Journal of Clinical Oncology 30:20, pages 2500-2508.
Crossref
Crossref
N. BIGLIA, V.E. BOUNOUS, A. MALABAILA, D. PALMISANO, D.M.E. TORTA, M. D'ALONZO, P. SISMONDI & R. TORTA. (2012) Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study. European Journal of Cancer Care 21:4, pages 485-492.
Crossref
Crossref
Stephanie A. Reid-Arndt & Cathy R. Cox. (2012) Stress, Coping and Cognitive Deficits in Women After Surgery for Breast Cancer. Journal of Clinical Psychology in Medical Settings 19:2, pages 127-137.
Crossref
Crossref
Vincent KoppelmansMonique M.B. BretelerWillem BoogerdCaroline SeynaeveChad GundySanne B. Schagen. (2012) Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy. Journal of Clinical Oncology 30:10, pages 1080-1086.
Crossref
Crossref
A. Ullrich, H. M. Böttcher & C. Bergelt. (2012) Geschlechtsspezifische Aspekte der Rückkehr zur Arbeit bei Patientinnen und Patienten mit einer KrebserkrankungGender-related aspects of returning to work in cancer survivors. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 55:4, pages 516-534.
Crossref
Crossref
Kristin M. Phillips, Heather S. Jim, Brent J. Small, Christine Laronga, Michael A. Andrykowski & Paul B. Jacobsen. (2011) Cognitive functioning after cancer treatment. Cancer 118:7, pages 1925-1932.
Crossref
Crossref
Mary Lou Galantino, Laurie Greene, Laura Daniels, Brandon Dooley, Laura Muscatello & Laura O'Donnell. (2012) Longitudinal Impact of Yoga on Chemotherapy-Related Cognitive Impairment and Quality of Life in Women with Early Stage Breast Cancer: A Case Series. EXPLORE 8:2, pages 127-135.
Crossref
Crossref
M. Tish Knobf, Leah M. Ferrucci, Brenda Cartmel, Beth A. Jones, Denise Stevens, Maureen Smith, Andrew Salner & Linda Mowad. (2011) Needs assessment of cancer survivors in Connecticut. Journal of Cancer Survivorship 6:1, pages 1-10.
Crossref
Crossref
Émilie Fortier-Brochu, Simon Beaulieu-Bonneau, Hans Ivers & Charles M. Morin. (2012) Insomnia and daytime cognitive performance: A meta-analysis. Sleep Medicine Reviews 16:1, pages 83-94.
Crossref
Crossref
Jin-Hee ParkSun Hyoung Bae. (2012) A Meta-analysis of Chemotherapy related Cognitive Impairment in Patients with Breast Cancer. Journal of Korean Academy of Nursing 42:5, pages 644.
Crossref
Crossref
Thane Fremouw, Christy L. Fessler, Robert J. Ferguson & Yamil Burguete. (2012) Preserved learning and memory in mice following chemotherapy: 5-Fluorouracil and doxorubicin single agent treatment, doxorubicin–cyclophosphamide combination treatment. Behavioural Brain Research 226:1, pages 154-162.
Crossref
Crossref
K. Kurita, B. E. Meyerowitz, P. Hall & M. Gatz. (2011) Long-term Cognitive Impairment in Older Adult Twins Discordant for Gynecologic Cancer Treatment. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 66A:12, pages 1343-1349.
Crossref
Crossref
Florence Joly, Olivier Rigal, Sabine Noal & Bénédicte Giffard. (2011) Cognitive dysfunction and cancer: which consequences in terms of disease management?. Psycho-Oncology 20:12, pages 1251-1258.
Crossref
Crossref
Jeffrey M. Long, Garrick D. Lee, Bennett Kelley-Bell, Edward L. Spangler, Evelyn J. Perez, Dan L. Longo, Rafael de Cabo, Sige Zou & Peter R. Rapp. (2011) Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats. Pharmacology Biochemistry and Behavior 100:1, pages 205-211.
Crossref
Crossref
Earllaine Croarkin & Min-Hui Huang. (2011) Screening Balance Deficits in Older Individuals Diagnosed With Cancer. Topics in Geriatric Rehabilitation 27:3, pages 244-251.
Crossref
Crossref
Karen L. SyrjalaSamantha B. ArtherholtBrenda F. KurlandShelby L. LangerSari Roth-RoemerJoAnn Broeckel ElrodSureyya Dikmen. (2011) Prospective Neurocognitive Function Over 5 Years After Allogeneic Hematopoietic Cell Transplantation for Cancer Survivors Compared With Matched Controls at 5 Years. Journal of Clinical Oncology 29:17, pages 2397-2404.
Crossref
Crossref
Seongmi Moon, Sun-Hee Kim & Mi-Ja Kim. (2011) Perceived Cognitive Function and Related Factors in Korean Women With Breast Cancer. Asian Nursing Research 5:2, pages 141-150.
Crossref
Crossref
Laura Lyons, Maha ElBeltagy, Jariya Umka, Rachel Markwick, Carla Startin, Geoffrey Bennett & Peter Wigmore. (2010) Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy. Psychopharmacology 215:1, pages 105-115.
Crossref
Crossref
Bernadine Cimprich, Moira Visovatti & David L. Ronis. (2011) The Attentional Function Index—a self‐report cognitive measure. Psycho-Oncology 20:2, pages 194-202.
Crossref
Crossref
Andreas A. Argyriou, Konstantinos Assimakopoulos, Gregoris Iconomou, Fotini Giannakopoulou & Haralabos P. Kalofonos. (2011) Either Called “Chemobrain” or “Chemofog,” the Long-Term Chemotherapy-Induced Cognitive Decline in Cancer Survivors Is Real. Journal of Pain and Symptom Management 41:1, pages 126-139.
Crossref
Crossref
S. Gérard & L. Balardy. 2011. Oncogériatrie. Oncogériatrie
151
158
.
Jennifer Jones & Eva Grunfeld. 2011. Health Services for Cancer Survivors. Health Services for Cancer Survivors
3
25
.
Lisa Beatty, Melissa Oxlad, Bogda Koczwara & Tracey D. Wade. (2010) A randomised pilot of a self-help workbook intervention for breast cancer survivors. Supportive Care in Cancer 18:12, pages 1597-1603.
Crossref
Crossref
B. POTRATA, J. CAVET, S. BLAIR, T. HOWE & A. MOLASSIOTIS. (2010) ‘Like a sieve’: an exploratory study on cognitive impairments in patients with multiple myeloma. European Journal of Cancer Care 19:6, pages 721-728.
Crossref
Crossref
Brenna C. McDonald, Susan K. Conroy, Tim A. Ahles, John D. West & Andrew J. Saykin. (2010) Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Research and Treatment 123:3, pages 819-828.
Crossref
Crossref
Fehmidah Munir, Jodie Burrows, Joanna Yarker, Katryna Kalawsky & Manpreet Bains. (2010) Women’s perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study. Journal of Clinical Nursing 19:9-10, pages 1362-1370.
Crossref
Crossref
Stephanie A. Reid‐Arndt, Catherine Hsieh & Michael C. Perry. (2010) Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer. Psycho-Oncology 19:5, pages 535-544.
Crossref
Crossref
Ollie MintonPatrick C Stone. (2010) Review: The use of proteomics as a research methodology for studying cancer-related fatigue: a review. Palliative Medicine 24:3, pages 310-316.
Crossref
Crossref
Maha ELBeltagy, Sarah Mustafa, Jariya Umka, Laura Lyons, Ahmed Salman, Chur-Yoe Gloria Tu, Nikita Bhalla, Geoffrey Bennett & Peter M. Wigmore. (2010) Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil. Behavioural Brain Research 208:1, pages 112-117.
Crossref
Crossref
Lisseth Calvio, Mark Peugeot, Gina L. Bruns, Briana L. Todd & Michael Feuerstein. (2010) Measures of Cognitive Function and Work in Occupationally Active Breast Cancer Survivors. Journal of Occupational & Environmental Medicine 52:2, pages 219-227.
Crossref
Crossref
Lisa M. Hess. 2010. Chemo Fog. Chemo Fog
37
54
.
Peter M. Wigmore, Sarah Mustafa, Maha El-Beltagy, Laura Lyons, Jariya Umka & Geoff Bennett. 2010. Chemo Fog. Chemo Fog
157
164
.
KATHARINE J. VEARNCOMBE, MARGARET ROLFE, MARGARET WRIGHT, NANCY A. PACHANA, BROOKE ANDREW & GEOFFREY BEADLE. (2009) Predictors of Cognitive Decline After Chemotherapy in Breast Cancer Patients. Journal of the International Neuropsychological Society 15:6, pages 951-962.
Crossref
Crossref
J. Weis, M. Poppelreuter & H. H. Bartsch. (2008) Cognitive deficits as long‐term side‐effects of adjuvant therapy in breast cancer patients: ‘subjective’ complaints and ‘objective’ neuropsychological test results. Psycho-Oncology 18:7, pages 775-782.
Crossref
Crossref
Karen Nieuwenhuijsen, Angela de Boer, Evelien Spelten, Mirjam A.G. Sprangers & Jos H. A. M. Verbeek. (2008) The role of neuropsychological functioning in cancer survivors' return to work one year after diagnosis. Psycho-Oncology 18:6, pages 589-597.
Crossref
Crossref
Laura S GilchristMary Lou GalantinoMeredith WamplerVictoria G MarcheseG Stephen MorrisKirsten K Ness. (2009) A Framework for Assessment in Oncology Rehabilitation. Physical Therapy 89:3, pages 286-306.
Crossref
Crossref
Mimi Mehlsen, Anders Degn Pedersen, Anders Bonde Jensen & Robert Zachariae. (2008) No indications of cognitive side‐effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psycho-Oncology 18:3, pages 248-257.
Crossref
Crossref
Barbara Collins, Joyce Mackenzie, Angela Stewart, Catherine Bielajew & Shailendra Verma. (2008) Cognitive effects of chemotherapy in post‐menopausal breast cancer patients 1 year after treatment. Psycho-Oncology 18:2, pages 134-143.
Crossref
Crossref
Janette Vardy. 2009. Adjuvant Therapy for Breast Cancer. Adjuvant Therapy for Breast Cancer
387
419
.
Annabel Pollard. 2009. Adjuvant Therapy for Breast Cancer. Adjuvant Therapy for Breast Cancer
219
238
.
Catherine E. Jansen, Marylin J. Dodd, Christine A. Miaskowski, Glenna A. Dowling & Joel Kramer. (2008) Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide. Psycho-Oncology 17:12, pages 1189-1195.
Crossref
Crossref
J. Vardy, J.S. Wefel, T. Ahles, I.F. Tannock & S.B. Schagen. (2008) Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Annals of Oncology 19:4, pages 623-629.
Crossref
Crossref
Julienne E. Bower. (2008) Behavioral Symptoms in Patients With Breast Cancer and Survivors. Journal of Clinical Oncology 26:5, pages 768-777.
Crossref
Crossref
Jame Abraham, Marc W. Haut, Maria T. Moran, Shannon Filburn, Susan Lemiuex & Hiroto Kuwabara. (2008) Adjuvant Chemotherapy for Breast Cancer: Effects on Cerebral White Matter Seen in Diffusion Tensor Imaging. Clinical Breast Cancer 8:1, pages 88-91.
Crossref
Crossref
Angela Stewart, Barbara Collins, Joyce Mackenzie, Eva Tomiak, Shailendra Verma & Catherine Bielajew. (2007) The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study. Psycho-Oncology 17:2, pages 122-130.
Crossref
Crossref
J Bernhard, D Zahrieh, J J Zhang, G Martinelli, R Basser, C Hürny, J F Forbes, S Aebi, W Yeo, B Thürlimann, M D Green, M Colleoni, R D Gelber, M Castiglione-Gertsch, K N Price, A Goldhirsch & A S Coates. (2007) Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer. British Journal of Cancer 98:1, pages 25-33.
Crossref
Crossref
Catherine E. Jansen, Christine A. Miaskowski, Marilyn J. Dodd & Glenna A. Dowling. (2007) A Meta-Analysis of the Sensitivity of Various Neuropsychological Tests Used to Detect Chemotherapy-Induced Cognitive Impairment in Patients With Breast Cancer. Oncology Nursing Forum 34:5, pages 997-1005.
Crossref
Crossref
FREDERICK W. UNVERZAGT, PATRICK O. MONAHAN, LYNDSI R. MOSER, QIANQIAN ZHAO, JANET S. CARPENTER, GEORGE W. SLEDGE & VICTORIA L. CHAMPION. (2007) The Indiana University Telephone-Based Assessment of Neuropsychological Status: A new method for large scale neuropsychological assessment. Journal of the International Neuropsychological Society 13:05.
Crossref
Crossref
Janette Vardy & Ian Tannock. (2007) Cognitive function after chemotherapy in adults with solid tumours. Critical Reviews in Oncology/Hematology 63:3, pages 183-202.
Crossref
Crossref
Daniel F. Hayes. (2007) Follow-up of Patients with Early Breast Cancer. New England Journal of Medicine 356:24, pages 2505-2513.
Crossref
Crossref